Tags LF01

Medicilon Assists Longsee Biomedical's live bacter..

A Story by Medicilon

On November 20, LF01, an innovative anti-tumor drug independently developed by Longsee Biomedical Co. Ltd. (Longsee Biomedical), received the NMPA dru..